Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Cardiovascular and Renal Outcomes in an Excellent Chronic Kidney Disease Clinic Compared with an Outpatient Clinic in a Primary Care Setting: A Retrospective Cohort Study.

Aiumtrakul N, Euswas K, Phichedwanichskul K, Rangsin R, Kaewput W, Satirapoj B.

Kidney Dis (Basel). 2019 Jun;5(3):144-152. doi: 10.1159/000495464. Epub 2019 Jan 3.

2.

Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study.

Satirapoj B, Pooluea P, Nata N, Supasyndh O.

J Diabetes Complications. 2019 Sep;33(9):675-681. doi: 10.1016/j.jdiacomp.2019.05.013. Epub 2019 May 25.

PMID:
31227289
3.

Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: a randomized controlled trial.

Satirapoj B, Korkiatpitak P, Supasyndh O.

Clin Kidney J. 2019 Jan 4;12(3):326-332. doi: 10.1093/ckj/sfy122. eCollection 2019 Jun.

4.

The authors' reply.

Satirapoj B, Vongwattana P, Supasyndh O.

Kidney Res Clin Pract. 2019 Mar 31;38(1):125-126. doi: 10.23876/j.krcp.19.006. No abstract available.

5.

Very low protein diet plus ketoacid analogs of essential amino acids supplement to retard chronic kidney disease progression.

Satirapoj B, Vongwattana P, Supasyndh O.

Kidney Res Clin Pract. 2018 Dec;37(4):384-392. doi: 10.23876/j.krcp.18.0055. Epub 2018 Dec 31.

6.

The association between renal function and neurological diseases in type 2 diabetes: a multicenter nationwide cross-sectional study.

Kaewput W, Thongprayoon C, Rangsin R, Mao MA, Satirapoj B, Cheungpasitporn W.

Hosp Pract (1995). 2019 Feb;47(1):46-52. doi: 10.1080/21548331.2019.1549916. Epub 2018 Nov 25.

PMID:
30445880
7.

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial.

Satirapoj B, Watanakijthavonkul K, Supasyndh O.

PLoS One. 2018 Oct 31;13(10):e0206722. doi: 10.1371/journal.pone.0206722. eCollection 2018.

8.
9.

Tubulointerstitial Biomarkers for Diabetic Nephropathy.

Satirapoj B.

J Diabetes Res. 2018 Feb 8;2018:2852398. doi: 10.1155/2018/2852398. eCollection 2018. Review.

10.

Efficacy and safety of subcutaneous administration of lyophilized powder of alfa-erythropoietin to maintain hemoglobin concentrations among hemodialysis patients.

Satirapoj B, Dispan R, Supasyndh O.

Int J Nephrol Renovasc Dis. 2017 Sep 20;10:275-283. doi: 10.2147/IJNRD.S143731. eCollection 2017.

11.

Sodium-Glucose Cotransporter 2 Inhibitors with Renoprotective Effects.

Satirapoj B.

Kidney Dis (Basel). 2017 Jul;3(1):24-32. doi: 10.1159/000471765. Epub 2017 Apr 8. Review.

12.

Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.

Satirapoj B, Kitiyakara C, Leelahavanichkul A, Avihingsanon Y, Supasyndh O.

BMC Nephrol. 2017 Aug 4;18(1):263. doi: 10.1186/s12882-017-0678-3.

13.

Nutritional status among peritoneal dialysis patients after oral supplement with ONCE dialyze formula.

Satirapoj B, Limwannata P, Kleebchaiyaphum C, Prapakorn J, Yatinan U, Chotsriluecha S, Supasyndh O.

Int J Nephrol Renovasc Dis. 2017 Jun 13;10:145-151. doi: 10.2147/IJNRD.S138047. eCollection 2017.

14.

Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.

Ruangkanchanasetr P, Sanohdontree N, Supaporn T, Sathavarodom N, Satirapoj B.

Ann Transplant. 2016 Dec 16;21:765-774.

15.
16.

Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study.

Satirapoj B, Aramsaowapak K, Tangwonglert T, Supasyndh O.

J Diabetes Res. 2016;2016:3102962. Epub 2016 Sep 8.

17.

Electrolyte disturbances and risk factors of acute kidney injury patients receiving dialysis in exertional heat stroke.

Satirapoj B, Kongthaworn S, Choovichian P, Supasyndh O.

BMC Nephrol. 2016 Jun 6;17(1):55. doi: 10.1186/s12882-016-0268-9.

18.

The effect of ONCE Renal on minerals and electrolytes in predialysis patients with chronic kidney disease.

Satirapoj B, Prapakorn J, Punpanich D, Pongsuparbchon C, Supasyndh O.

Int J Nephrol Renovasc Dis. 2016 Apr 5;9:81-6. doi: 10.2147/IJNRD.S98179. eCollection 2016.

19.

Benefits of Allopurinol Treatment on Blood Pressure and Renal Function in Patients with Early Stage of Chronic Kidney Disease.

Satirapoj B, Wirajit O, Burata A, Supasyndh O, Ruangkanchanasetr P.

J Med Assoc Thai. 2015 Dec;98(12):1155-61.

PMID:
27004299
20.

BIOPSY-PROVEN BK VIRUS NEPHROPATHY WITHOUT DETECTABLE BK VIREMIA IN A ONE-YEAR POST-KIDNEY TRANSPLANT RECIPIENT.

Ruangkanchanasetr P, Pumchandh N, Satirapoj B, Termmathurapoj S, Pongthanapisith V.

Southeast Asian J Trop Med Public Health. 2015 Jul;46(4):657-61.

PMID:
26867385
21.

A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience.

Anutrakulchai S, Panaput T, Wongchinsri J, Chaishayanon S, Satirapoj B, Traitanon O, Pima W, Rukrung C, Thinkhamrop B, Avihingsanon Y.

Lupus Sci Med. 2016 Jan 14;3(1):e000120. doi: 10.1136/lupus-2015-000120. eCollection 2016.

22.

The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease.

Satirapoj B, Promrattanakun A, Supasyndh O, Choovichian P.

Int J Nephrol. 2015;2015:485839. doi: 10.1155/2015/485839. Epub 2015 Oct 12.

23.

Performance of the estimated glomerular filtration rate creatinine and cystatin C based equations in Thai patients with chronic glomerulonephritis.

Satirapoj B, Jirawatsiwaporn K, Tangwonglert T, Choovichian P.

Int J Nephrol Renovasc Dis. 2015 Oct 21;8:145-50. doi: 10.2147/IJNRD.S93866. eCollection 2015.

24.

Metabolic Syndrome in Thai Renal Transplant Recipients: A Multicenter Study.

Ruangkanchanasetr P, Bunnag S, Vongwiwatana A, Premasathian N, Avihingsanon Y, Gojaseni P, Supaporn T, Satirapoj B.

Ann Transplant. 2015 Aug 27;20:500-5. doi: 10.12659/AOT.893664.

26.

Prevalence and Management of Diabetic Nephropathy in Western Countries.

Satirapoj B, Adler SG.

Kidney Dis (Basel). 2015 May;1(1):61-70. doi: 10.1159/000382028. Epub 2015 May 1. Review.

27.

Effect of sulodexide on urinary biomarkers of kidney injury in normoalbuminuric type 2 diabetes: a randomized controlled trial.

Satirapoj B, Kaewput W, Supasyndh O, Ruangkanchanasetr P.

J Diabetes Res. 2015;2015:172038. doi: 10.1155/2015/172038. Epub 2015 Mar 31.

28.

Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.

Satirapoj B, Tassanasorn S, Charoenpitakchai M, Supasyndh O.

PLoS One. 2015 Apr 17;10(4):e0124055. doi: 10.1371/journal.pone.0124055. eCollection 2015.

29.

Clinicopathological correlation in asian patients with biopsy-proven lupus nephritis.

Satirapoj B, Tasanavipas P, Supasyndh O.

Int J Nephrol. 2015;2015:857316. doi: 10.1155/2015/857316. Epub 2015 Mar 19.

30.

Urinary angiotensinogen as a potential biomarker of diabetic nephropathy.

Satirapoj B, Siritaweesuk N, Supasyndh O.

Clin Kidney J. 2014 Aug;7(4):354-60. doi: 10.1093/ckj/sfu059. Epub 2014 Jul 15.

31.

Periostin: a novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients.

Wantanasiri P, Satirapoj B, Charoenpitakchai M, Aramwit P.

Lupus. 2015 Jul;24(8):835-45. doi: 10.1177/0961203314566634. Epub 2015 Jan 14.

PMID:
25593049
33.

Comprehensive approach to diabetic nephropathy.

Satirapoj B, Adler SG.

Kidney Res Clin Pract. 2014 Sep;33(3):121-31. doi: 10.1016/j.krcp.2014.08.001. Epub 2014 Sep 10. Review.

34.

Short-term administration of an angiotensin II receptor blocker in patients with long-term hemodialysis patients improves insulin resistance.

Satirapoj B, Leelasiri K, Supasyndh O, Choovichian P.

J Med Assoc Thai. 2014 Jun;97(6):574-81.

PMID:
25137874
35.

Intensive plasmapheresis and intravenous immunoglobulin for treatment of antibody-mediated rejection after kidney transplant.

Ruangkanchanasetr P, Satirapoj B, Termmathurapoj S, Namkhanisorn K, Suaywan K, Nimkietkajorn V, Luesutthiviboon L.

Exp Clin Transplant. 2014 Aug;12(4):328-33.

36.

High prevalence of obesity in Thai renal transplant recipients: a multicenter study.

Ruangkanchanasetr P, Satirapoj B, Bunnag S, Vongwiwatana A, Premasathian N, Avihingsanon Y.

Transplant Proc. 2014;46(2):546-51. doi: 10.1016/j.transproceed.2013.11.057.

PMID:
24656009
37.

Urine periostin as a biomarker of renal injury in chronic allograft nephropathy.

Satirapoj B, Witoon R, Ruangkanchanasetr P, Wantanasiri P, Charoenpitakchai M, Choovichian P.

Transplant Proc. 2014 Jan-Feb;46(1):135-40. doi: 10.1016/j.transproceed.2013.07.069.

PMID:
24507039
38.

Apolipoprotein E genetic polymorphisms and the development of nephropathy in type 2 diabetes.

Satirapoj B, Supasyndh O, Dispan R, Punpanich D, Tribanyatkul S, Choovichian P.

J Med Assoc Thai. 2013 Sep;96(9):1119-26.

PMID:
24163986
39.

Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population.

Satirapoj B, Limwannata P, Chaiprasert A, Supasyndh O, Choovichian P.

BMC Nephrol. 2013 Oct 2;14:206. doi: 10.1186/1471-2369-14-206.

40.

Nephropathy in diabetes.

Satirapoj B.

Adv Exp Med Biol. 2012;771:107-22. Review.

PMID:
23393675
41.

Obesity and its relation to chronic kidney disease: a population-based, cross-sectional study of a Thai army population and relatives.

Satirapoj B, Supasyndh O, Mayteedol N, Punpanich D, Chaiprasert A, Nata N, Ruangkanchanasetr P, Kanjanakul I, Choovichian P.

Nephrology (Carlton). 2013 Mar;18(3):229-34. doi: 10.1111/nep.12023.

PMID:
23279639
42.

Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients.

Supasyndh O, Satirapoj B, Aramwit P, Viroonudomphol D, Chaiprasert A, Thanachatwej V, Vanichakarn S, Kopple JD.

Clin J Am Soc Nephrol. 2013 Feb;8(2):271-9. doi: 10.2215/CJN.00380112. Epub 2012 Nov 2.

43.

Isometric tubular vacuolization in renal transplant recipient: the first case report in Thailand.

Ruangkanchanasetr P, Praechinavong W, Paueksakon P, Satirapoj B, Supasyndh O, Supaporn T.

J Med Assoc Thai. 2012 May;95 Suppl 5:S168-71.

PMID:
22934464
44.

Oxidized low-density lipoprotein antigen transport induces autoimmunity in the renal tubulointerstitium.

Satirapoj B, Bruhn KW, Nast CC, Wang Y, Dai T, Lapage J, Wu X, Natarajan R, Adler SG.

Am J Nephrol. 2012;35(6):520-30. doi: 10.1159/000338484. Epub 2012 May 25.

45.

Novel insights into the relationship between glomerular pathology and progressive kidney disease.

Satirapoj B, Nast CC, Adler SG.

Adv Chronic Kidney Dis. 2012 Mar;19(2):93-100. doi: 10.1053/j.ackd.2011.12.001. Review.

PMID:
22449346
46.

Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells.

Satirapoj B, Wang Y, Chamberlin MP, Dai T, LaPage J, Phillips L, Nast CC, Adler SG.

Nephrol Dial Transplant. 2012 Jul;27(7):2702-11. doi: 10.1093/ndt/gfr670. Epub 2011 Dec 13.

47.

Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.

Satirapoj B, Supasyndh O, Phantana-Angkul P, Ruangkanchanasetr P, Nata N, Chaiprasert A, Kanjanakul I, Choovichian P.

J Med Assoc Thai. 2011 Sep;94 Suppl 4:S87-93.

PMID:
22043573
48.

A single-centre experience: peritoneal dialysis-related infections in patients on long-term dialysis.

Luvira V, Satirapoj B, Supasyndh O, Chaiprasert A, Ruangkanchanasetr P, Nata N, Kanjanakul I, Supaporn T, Choovichian P, Bijaphala S, Luvira U, Phiboonbanakit D.

J Med Assoc Thai. 2011 Sep;94 Suppl 4:S30-6.

PMID:
22043564
49.

Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across species.

Patel-Chamberlin M, Wang Y, Satirapoj B, Phillips LM, Nast CC, Dai T, Watkins RA, Wu X, Natarajan R, Leng A, Ulanday K, Hirschberg RR, Lapage J, Nam EJ, Haq T, Adler SG.

Kidney Int. 2011 May;79(10):1138-48. doi: 10.1038/ki.2011.28. Epub 2011 Mar 9.

50.

Metabolic syndrome and its relation to chronic kidney disease in a Southeast Asian population.

Satirapoj B, Supasyndh O, Mayteedol N, Chaiprasert A, Choovichian P.

Southeast Asian J Trop Med Public Health. 2011 Jan;42(1):176-83.

PMID:
21323181

Supplemental Content

Loading ...
Support Center